OCS appointed Snehal Shah as President of R&D on August 12, 2025.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
OCS appointed Snehal Shah as President of R&D on August 12, 2025.
Who's involved
What this event is mainly aboutOCSSnehal Shah
Keep exploring
The entities involved
-
OCS
company based in Latvia
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireOculis to Participate in Upcoming H.C Wainwright 5th Annual Ophthalmology Virtual Conference ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”),